State Of Wisconsin Investment Board Black Diamond Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.43 - $6.18 $12,012 - $51,912	-8,400 Reduced 40.98%	12,100 $61,000
Q1 2023 May 15, 2023	SELL	$1.35 - $3.14 $27,945 - $64,998	-20,700 Reduced 50.24%	20,500 $38,000
Q4 2022 Feb 14, 2023	SELL	$1.27 - $2.51 $29,591 - $58,482	-23,300 Reduced 36.12%	41,200 $74,000
Q3 2022 Nov 14, 2022	SELL	$1.68 - $4.01 $43,848 - $104,661	-26,100 Reduced 28.81%	64,500 $109,000
Q2 2022 Aug 15, 2022	SELL	$1.5 - $3.63 $29,850 - $72,237	-19,900 Reduced 18.01%	90,600 $223,000
Q1 2022 May 13, 2022	BUY	$2.66 - $5.61 $293,930 - $619,905	110,500 New	110,500 $306,000
Q2 2021 Aug 12, 2021	SELL	$12.19 - $28.17 $297,436 - $687,348	-24,400 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$22.23 - $34.75 $24,453 - $38,225	-1,100 Reduced 4.31%	24,400 $592,000
Q4 2020 Feb 03, 2021	BUY	$29.47 - $35.0 $203,343 - $241,500	6,900 Added 37.1%	25,500 $817,000
Q1 2020 May 06, 2020	BUY	$18.18 - $39.48 $338,148 - $734,328	18,600 New	18,600 $464,000

121

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $89.4M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.